Fungal Ecdysteroid-22-oxidase, a New Tool for Manipulating Ecdysteroid Signaling and Insect Development by Kamimura Manabu et al.
Fungal Ecdysteroid-22-oxidase, a New Tool for
Manipulating Ecdysteroid Signaling and Insect
Development
著者 Kamimura Manabu, Saito Hitoshi, Niwa Ryusuke,
Niimi Teruyuki, Toyoda Kinuko, Ueno Chihiro,
Kanamori Yasushi, Shimura Sachiko, Kiuchi
Makoto
journal or
publication title
The journal of biological chemistry
volume 287
number 20
page range 16488-16498
year 2012-05
権利 This research was originally published in J
Biol Chem. Kamimura M. et.al. Fungal
Ecdysteroid-22-oxidase, a New Tool for
Manipulating Ecdysteroid Signaling and Insect
Development. J Biol Chem. 2012;
287(20):16488-16498. (C) the American Society
for Biochemistry and Molecular Biology.
URL http://hdl.handle.net/2241/117378
doi: 10.1074/jbc.M112.341180
 1 
 
Fungal ecdysteroid-22-oxidase: a new tool for manipulating ecdysteroid signaling and insect 
development 
 
 
Manabu Kamimura‡1, Hitoshi Saito‡2, Ryusuke Niwa§, Teruyuki Niimi¶, Kinuko Toyoda‡3, 
Chihiro Ueno‡, Yasushi Kanamori‡4, Sachiko Shimura‡, and Makoto Kiuchi‡ 
 
‡From National Institute of Agrobiological Sciences, Owashi, Tsukuba, Ibaraki 305-8634, Japan 
§Initiative for the Promotion of Young Scientists' Independent Research, Graduate School of Life and 
Environmental Sciences, University of Tsukuba, Tennoudai, Tsukuba, Ibaraki 305-8572, Japan 
¶Graduate School of Bioagricultural Sciences, Nagoya University, Chikusa, Nagoya 464-8601, Japan 
 
*Running title: Fungal ecdysteroid inactivation enzyme 
 
1To whom correspondence should be addressed: Manabu Kamimura, Division of Insect Science, 
National Institute of Agrobiological Sciences, 1-2 Owashi, Tsukuba, Ibaraki 305-8634, Japan, Tel.: 
+81(298) 38-6073; Fax: +81(298) 38-6028; E- mail: kamimura@affrc.go.jp 
 
Keywords:  ecdysone, metamorphosis, diapause, embryogenesis, Bombyx mori, Nomuraea rileyi     
 
Background: Artificial reduction of internal 
ecdysteroid titer is very difficult to achieve 
in insects. 
 
Results: Injection of Nomuraea rileyi 
ecdysteroid-22-oxidase (E22O) or forced 
expression of E22O gene reduced 
ecdysteroid titer and manipulated 
embryogenesis, molting, metamorphosis, and 
diapause in a number of insects. 
 
Conclusion: E22O is the first versatile 
ecdysteroid titer-decreasing tool. 
 
Significance: E220 will be used to answer 
various ecdysteroid-associated 
developmental and physiological questions.  
 
SUMMARY 
Steroid hormones ecdysteroids regulate 
varieties of developmental processes in 
insects.  Although the ecdysteroid titer can 
be increased experimentally with ease, its 
artificial reduction, though desirable, is 
very difficult to achieve. Here we 
characterized the ecdysteroid-inactivating 
enzyme ecdysteroid-22-oxidase (E22O) 
from the entomopathogenic fungus 
Nomuraea rileyi and used it to develop 
methods for reducing ecdysteroid titer 
and thereby controlling insect 
development. Km and Kcat values of the 
purified E22O for oxidizing ecdysone were 
4.4 µM and 8.4/s, respectively, indicating 
that E22O can inactivate ecdysone more 
efficiently than other ecdysteroid 
inactivating enzymes characterized so far. 
The cloned E22O cDNA encoded a FAD-
dependent oxidoreductase. Injection of 
recombinant E22O into the silkworm 
Bombyx mori interfered with larval 
molting and metamorphosis. In the 
hemolymph of E22O-injected pupae, the 
titer of hormonally active 20-
hydroxyecdysone decreased and 
concomitantly large amounts of inactive 
22-dehydroecdysteroids accumulated. 
E22O injection also prevented molting of 
various other insects. In the larvae of the 
crambid moth Haritalodes basipunctalis, 
E22O injection induced a diapause-like 
developmental arrest, which, as in normal 
diapause, was broken by chilling. 
Transient expression of the E22O gene by 
in vivo lipofection effectively decreased the 
20-hydroxyecdysone titer and blocked 
molting in B. mori. Transgenic expression 
of E22O in Drosophila melanogaster 
caused embryonic morphological defects, 
phenotypes of which were very similar to 
those of the ecdysteroid synthesis deficient 
mutants. Thus, as the first available 
simple but versatile tool for reducing the 
internal ecdysteroid titer, E22O could find 
use in controlling a broad range of 
ecdysteroid-associated developmental and 
physiological phenomena.     
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 In insects, the steroid hormones 
ecdysteroids, primarily 20-hydroxyecdysone 
(20E), play important roles in the regulation 
of various developmental and physiological 
processes such as embryogenesis, molting, 
metamorphosis, reproduction and diapause 
(1-4). Titers of ecdysteroids are precisely 
controlled by a combination of synthetic 
reactions, most of which proceed in the 
prothoracic gland, whereas they are 
inactivated in various peripheral organs (5). 
In the last decade, eight ecdysteroid 
synthesis enzymes were identified, mainly 
from the fruit fly Drosophila melanogaster 
and silkworm Bombyx mori (6-16). Five of 
these enzymes were cytochrome P450 
encoded by the so-called Halloween genes of 
D. melanogater and mutants of which were 
all embryonic lethal (17).  In contrast, the 
ecdysteroid inactivation process has received 
relatively less attention. So far, four 
ecdysteroid inactivation enzymes have been 
identified in insects (18-23). Mutations in or 
knockdown of those genes interfered with 
the insect metamorphoses (21-23), indicating 
that both synthesis and inactivation of 
ecdysteroids are essential for the normal 
development of insects.  
 Some insect pathogens also use 
ecdysteroid inactivation enzymes. The best-
known example is the baculoviruses, which 
express the ecdysteroid UDP-
glucosyltransferase that inactivates 
ecdysteroids via sugar conjugation at 
position C22 (24). Another example is the 
entomopathogenic fungus Nomuraea rileyi 
that secretes the ecdysteroid-22-oxidase 
(E22O) that oxidizes the hydroxyl group at 
C22 to a carbonyl group (25) (Fig. 1). These 
pathogens inhibit molting of their hosts by 
inactivating the host ecdysteroid hormones 
using these enzymes, presumably to maintain 
a good physiological condition for growth 
(25,26) 
 These ecdysteroid inactivation 
enzymes could potentially serve as powerful 
tools in ecdysteroid research, as techniques 
for both increasing and decreasing internal 
titers of hormones are essential for analyzing 
their actions in vivo. Indeed, increases in the 
ecdysteroid titer experimentally, by injecting 
or feeding exogenous ecdysteroid, have 
revealed various biological functions and 
modes of action of this hormone in a number 
of insect species (1-4). A reduction in the 
ecdysteroid titer using artificial means is, 
however, very difficult to achieve in most 
insects, because the prothoracic glands are 
intricately-shaped organs and are difficult to 
remove completely by surgical operation. 
Furthermore, pharmacological agents that 
could inhibit synthesis or actions of 
ecdysteroids in a wide spectrum of insects 
have not been developed yet, and 
knockdown of genes encoding the 
ecdysteroid synthesis enzymes or forced 
expression of genes encoding the ecdysteroid 
inactivation enzymes is still difficult, except 
in D. melanogaster. Consequently, we do not 
know exactly what happens when the 
internal ecdysteroid titer is artificially 
decreased in most insects. The ecdysteroid 
inactivating enzymes could potentially solve 
this longstanding challenge. Particularly, 
E22O of N. rileyi is a good candidate for this 
purpose, because the B. mori larvae that were 
injected with the N. rileyi conditioned culture 
medium, which contained E22O activity, 
showed decreased level of ecdysteroid titer 
(25).  
 In this study, we characterized E22O 
and used it for developing methods to reduce 
the ecdysteroid titer. Injection of 
recombinant E22O protein or forced 
expression of E22O gene reduced the titer of 
20E and blocked embryogenesis, larval 
molting, larval-pupal or pupal (nymphal)-
adult metamorphoses in a number of insects. 
In addition, injection of E22O induced a 
diapause-like developmental arrest in the 
crambid moth Haritalodes basipunctalis that 
was indistinguishable from the normal 
diapause. To the best of our knowledge, this 
is the first report indicating that a reduction 
in the ecdysteroid titer is a sufficient 
endocrinological stimulus to induce 
diapauses in insects. Thus, our results 
suggest that E22O, by reducing the 
ecdysteroid titer, could serve as a powerful 
tool for researching a variety of ecdysteroid-
dependent phenomena during insect 
development.  
 
 
EXPERIMENTAL PROCEDURES  
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 Insects and fungus- The F1 hybrid 
strain C145 x N140 of Bombyx mori 
maintained in NIAS and Lucilia sericata 
purchased from a fishing-tackle store were 
reared on an artificial diet for silkworm 
(Nihon Nosan Kogyo). Naxa seriaria and 
Riptortus clavatus were collected in Tsukuba, 
Japan and reared on Ligustrum obtusifolium 
leaves and soybeans, respectively. Tenebrio 
molitor was purchased from a pet shop and 
reared on a powdered bird food. These 
insects were reared at 25°C under a 12 h 
light: 12 h dark (12L:12D) photoperiod. 
Haritalodes basipunctalis was collected in 
Tsukuba and reared on Firmiana simplex 
leaves at 25°C under 16L:8D photoperiod 
(non-diapausing condition) or at 17°C under 
8L:16D photoperiod (diapause-inducing 
condition). D. melanogaster were reared on a 
standard agar-cornmeal medium at 25°C 
under 12L:12D photoperiod. Mutant strain 
hsp70-GAL4 was obtained from the 
Drosophila Genetic Resource Center at 
Kyoto Institute of Technology. Mutant 
strains engrailed -GAL4 and Actin5C-GAL4 
were obtained from the Bloomington Stock 
Center. The Actin5C-GAL4 strain was 
originally established by Dr. Yasushi Hiromi 
at the National Institute for Genetics, Japan. 
N. rileyi, maintained in NIAS, was cultured 
in a medium containing 20 g of maltose, 5 g 
of tryptone and 5 g of yeast extract in 1 L 
water. Conditioned media for N. rileyi were 
prepared as described previously (25).  
 Ecdysteroids and brassinosteroids- 
Ecdysone (Sigma) and 20-hydroxyecdysone 
(Mitaka Pharmaceutical Co.) were purified 
using HPLC (LC-10AT, Shimadzu). Each 
ecdysteroid was applied to a C18 reverse-
phase column (TSK gel ODS-80Ts, 4.6 x 
150 mm, TOSOH) and then eluted with a 20 
to 30% linear gradient of acetonitrile using a 
flow rate of 0.6 ml/min. Fractions 
corresponding to each ecdysteroid were 
pooled, methanol was evaporated off, and 
dried ecdysteroid was weighed and then 
dissolved in ethanol. 22-Dehydroecdysone 
and 22-dehydro-20-hydroxyecdysone were 
synthesized by reacting ecdysone and 20-
hydroxyecdysone, respectively, with the 
conditioned media of Sf9-E22O cells. They 
were then purified by HPLC as above, 
weighed, and dissolved in ethanol. HPLC 
analysis confirmed that these ecdysteroids 
were >99% pure.  
 Ponasterone A (Invitrogen), 
brassinolide (Wako), and castasterone 
(Wako) were dissolved in ethanol.  
 Those ecdysteroid and 
brassinosteroid solutions were diluted with 
distilled water and reacted with E22O-
containing solutions.   
 E22O activity assay- An aliquot of 
E22O-containing solution was mixed with an 
equal volume of 200 µM of ecdysone and 
incubated at 25°C.  Ten min later, double 
volume of ethanol was added to stop the 
reaction and the mixture was centrifuged at 
18,000g for 10 min. Ecdysone and 
synthesized 22-dehydroecdysone remaining 
in the supernatant were separated by HPLC 
and the amount of 22-dehydroecdysone was 
calculated from the ratios of peak areas of 
the two ecdysteroids. Km and Vmax values 
were calculated using the GraphPad Prism 5 
program (GraphPad Software).  
 Purification of E22O- The N. rileyi 
conditioned medium (152 ml) was mixed 
with a protease inhibitor cocktail and solid 
ammonium sulfate was then added to achieve 
50% saturation, and the mixture was 
continuously stirred at 4°C over night. After 
centrifugation at 10,000g for 20 minutes, 
E22O was purified from the resulting 
supernatant by HPLC (Model Bio-HPLC 
system, TOSOH). The crude extract was 
applied to a HiTrap Phenyl-Sepharose HP 
column (Amersham Pharmacia Biotech) 
equilibrated with buffer A [20 mM Tris-HCl 
(pH 7.6)] containing 50% ammonium sulfate. 
The column was eluted using a linear 
gradient (50 - 0%) of ammonium sulfate in 
buffer A. Fractions containing E22O were 
pooled, dialyzed against buffer A containing 
0.3M NaCl, and concentrated using an 
Ultrafree Biomax-5 Centrifugal filter 
(Millipore). The concentrated solution was 
then applied to a Superdex 200 pg (1.6 × 60 
cm) column equilibrated with buffer A 
containing 0.3M NaCl. Fractions containing 
E22O were pooled and concentrated using 
the Ultrafree Biomax-5 Centrifugal filter 
again. The concentrated E22O was further 
purified using a HiTrap Q column 
(Amersham Pharmacia Biotech). Fractions 
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containing E22O (0.58 mg) were pooled and 
used for biochemical characterization. The 
molecular mass of the purified E22O was 
estimated by running it on a 15% 
polyacrylamide gel containing 0.1% SDS 
along with molecular weight marker proteins 
as standards. The molecular mass of E22O 
was also estimated by comparing its 
retention time on gel-filtration column 
(Superdex 200 prep grade, 10 mm x 30 cm 
column, equilibrated with buffer a containing 
0.3 M NaCl) with the retention times of the 
molecular weight marker proteins.  
 Amino acid sequencing- The N-
terminal sequence of the purified E22O was 
determined using a gas phase protein 
sequencer (Model LF-3400 DT, Beckman). 
Phenylthiohydantoin derivatives of 
individual amino acids were identified by 
reverse phase HPLC. The purified E22O was 
subjected to in-gel digestion by V8 protease 
and the products were separated on SDS-
PAGE. The N-terminal sequence of one of 
the protease-digested products was also 
determined as above.  
 cDNA cloning of E22O- Total RNA 
was extracted from the N. rileyi mycelia 
using TRIzol (Invitrogen) and reverse-
transcribed using Ready-To-Go T-Prime 
First-Strand Beads (Amersham Pharmacia 
Biotech). A partial E22O cDNA was cloned 
from the cDNA pool by PCR. Forward and 
reverse PCR primers were designed on the 
basis of the N-terminal sequences of the 
purified E22O and its limited V8-proteolysis 
product, respectively. The first PCR was 
carried out using the E22O-dF1 (5'-
TICCICARGGIGGITGYAG-3') and E22O-
dR1 (5'-CAIGCITTITTIACRTTRTG-3') 
primers. The second nested PCR was carried 
out using the E22O-dF2 (5'-
TGYAGRTGYATICCIGGIGA-3') and 
E22O-dR2 (5'-TTIACITTITGICCYTGRTC-
3') primers. The full-length E22O cDNA was 
obtained by combining 5'-RACE and 3'-
RACE reactions with primers that were 
designed based on the sequences of the 
partial E22O cDNA using SMART RACE 
cDNA Amplification Kit (Clontech). The 
nucleotide sequence of the full-length E22O 
cDNA was deposited in the 
GenBankTM/EMBL/DDBJ databases 
(accession number AB675078). A putative 
secretion signal of E22O was predicted using 
the SignalP 3.0 program (27).   
 Expression of E22O in cultured cell- 
The entire open reading frame of E22O was 
amplified by RT-PCR from the N. rileyi 
cDNA pool and cloned into the pIZT/V5-His 
expression vector (Invitrogen), and the 
resultant plasmid was called pIZT-E22O. 
The moth Spodoptera frugiperda Sf9 cells 
were transfected with pIZT-E22O using 
FuGENE HD (Roche Diagnostics). The Sf9 
cells transfected with pIZT-E22O were 
subcultured continuously in IPL-41 medium 
containing 10% FBS and 300 µg/ml of 
zeocin. Three months later, all cells acquired 
resistance against zeocin. We assumed that 
the plasmid pIZT-E22O got integrated into 
the genome of the Sf9 cells (designated 
hereafter as Sf9-E22O cells) and maintained 
them in IPL-41 medium with 10% FBS and 
10 µg/ml of zeocin. When they reached 80-
90% confluency, the medium was replaced 
with IPL-41 without FBS and zeocin. Two 
weeks later, the conditioned culture medium, 
which contained a large amount of E22O 
(Fig. S1A) but little FBS and zeocin, was 
collected. Because the activity of E22O in 
the medium remained high for a long period 
at 4 °C (Fig. S1C), we stored it in the 
refrigerator until used later in physiological 
experiments. Control conditioned medium 
was similarly prepared from the parental Sf9 
cells.  In physiological experiments, the 
conditioned medium of Sf9-E22O or Sf9 
cells (5-30 µl) was injected into the 
hemocoel of insects using a micro-syringe 
(Hamilton) with a 31 gauge ponit-4 needle.   
 Transient expression of E22O gene 
in silkworm- The E22O gene was expressed 
transiently in B. mori by in vivo lipofection 
following a slightly modified version of our 
published procedure (28).  Briefly, 2 µg of 
pIZT-E22O was mixed with 5 µl of Transfast 
(Promega) in 10 ml of 10 mM Tris-HCl 
buffer (pH 8.0), incubated for 10 min at 
room temperature, and then injected into the 
hemocoel of the silkworm larvae. As the 
control, the empty pIZT/V5-His plasmid was 
similarly lipofected into the silkworm larvae.  
 Transgenic expression of E22O gene 
in fruit fly-The entire coding region of E22O 
cDNA from pIZT-E22O was cloned into the 
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Eco RI/Bgl II site of the pUAST vector (29). 
The embryos used as recipients for DNA 
injection to generate transgenic lines were 
yellow white (y ac w1118) flies. Transgenic 
flies carrying UAS-E22O constructs (UAS-
E22O line) were generated as described 
previously (30). The UAS-E22O line was 
crossed with different GAL4 driver lines and 
F1 individuals were used for experiments. 
 Quantification of ecdysteroid titer- 
Hemolymph samples were individually 
collected from B. mori pupa or H. 
basipunctalis larvae, mixed vigorously with 
triple volume of methanol, and centrifuged at 
18,000g for 5 min. D. melanogaster embryos 
were collected as batches 7-12 h after egg 
laying, a time when embryonic ecdysteroid 
titer is the highest (31), homogenized in 
methanol, and then centrifuged. Total 
ecdysteroid content in the supernatant of 
these samples were measured by 
radioimmunoassay using 20E as a standard 
(32). Supernatant from the B. mori sample 
was run on HPLC and a fraction containing 
ecdysone, 20E, 22-dehydroecdysone, or 22-
dehydro-20-hydroxyecdysone was collected 
separately. The fractions were dried, 
dissolved in methanol again, and subjected to 
radioimmunoassay using each ecdysteroid as 
a standard.  The affinities of the antibody 
used in radioimmunoassay to ecdysone, 20E, 
22-dehydroecdysone, and 22-dehydro-20-
hydroxyecdysone were approximately 1: 3: 
0.3: 1.   
 Statistical analysis- Student's t-test 
was conducted to detect statistically 
significant differences between E22O 
treatments and controls using the JMP7 
software (SAS Institute).  
 
 
RESULTS 
 Purification, kinetic analysis, and 
cDNA cloning of E22O- As previously 
shown by us (25), the conditioned culture 
media of N. rileyi exhibited strong E22O 
activity (Fig. S1A). We therefore purified 
E22O from the N. rileyi conditioned medium 
by HPLC, sequentially using hydrophobic 
interaction chromatography, gel-filtration 
chromatography and ion exchange 
chromatography, and at the end obtained 
E22O as a single peak (Fig. 2, A-C).  The 
molecular mass of the purified E22O was 
estimated to be 76 kDa by both SDS-PAGE 
and gel-filtration analyses (Fig. 2, D and E), 
suggesting that E22O is a monomeric protein. 
 E22O exhibited highest catalytic 
activity for ecdysone at pH 10.5, and the 
activity decreased to one-third of this value 
at neutral pH (Fig. S2). Because the 
endogenous E22O normally works at neutral 
pH in the insect hemolymph, we measured 
the kinetic properties of the purified E22O at 
pH 7.0. The Kcat of the purified E22O for 
ecdysone was 8.4/s, which was three times 
higher than that for 20E; in contrast, the Km 
values were same (i.e., 4.3 µM) for both 
ecdysteroids (Fig. 2F). This observed Kcat of 
the purified E22O for ecdysone was much 
higher than those of the ecdysteroid UDP-
glucosyltransferase of the Autographa 
californica nucleopolyhedrovirus (Kcat = 
0.069/s) and ecdysone oxidase of the cotton 
leafworm Spodoptera littoralis (Kcat = 0.11-
0.12/s, calculated assuming that the 
molecular mass of the enzyme is 190 kDa), 
while the Km values of all three enzymes for 
ecdysone were similar (19,33). These results 
suggest that E22O inactivate ecdysone much 
more efficiently than the two other well-
characterized ecdysteroid inactivation 
enzymes.  E22O also oxidized and 
inactivated other ecdysteroids that contain 
the hydroxyl group at C22, for example 
ponasterone A, however, had no effect on 
plant steroid hormones brassinosteroids, such 
as brassinolide and castasterone, even though 
they also have the hydroxyl group at C22 
(data not shown).   
 Next, to clone the E22O cDNA, we 
first sequenced the N-termini of the purified 
E22O protein and one of the peptides 
produced by limited hydrolysis of E22O 
using V8 protease (Fig. S3). Using 
degenerated primers, designed on the basis 
of these amino acid sequences, a partial 
E22O cDNA fragment was cloned by RT-
PCR. The 5' and 3' ends of the E22O cDNA 
were then cloned using the 5’- and 3’-RACE 
techniques. The full length E22O cDNA 
encoded a novel FAD-binding 
oxidoreductase comprising of 594 amino 
acids (Fig. S3). Consistent with the 
prediction that E22O is a flavoprotein, 
purified E22O had a brownish color with an 
 6 
absorbance at 454 nm. The N-terminal end of 
E22O contained a putative signal peptide, 
and the amino acid sequence following it 
matched with the N-terminal sequence of the 
purified protein as determined above, 
suggesting that E22O is processed after the 
signal peptide and secreted from the cells. 
The amino acid sequence of E22O was up to 
55% identical to those of the alcohol 
oxidases identified from various fungi (Fig. 
S3). Although some of these oxidases are 
involved in the biosynthesis of biologically 
active agents, such as Hypomyces 
subiculosus alcohol oxidase involved in 
hypothemycin synthesis and Fusarium 
incarnatum APS9 in apicidin synthesis 
(34,35), none of them are known to be 
involved in the modification of steroids or 
hormones.  
 Activity of recombinant E22O- When 
the E22O cDNA was transiently expressed in 
Sf9 cells, high ecdysone-oxidizing activity 
was found in the culture media (Fig. S1A). 
Remarkably, 50 µl of the media completely 
oxidized equal volume of 200 µM (100 µM 
final concentration) of ecdysone within 10 
min (Fig. S1B); this final concentration of 
ecdysone was hundred times higher than the 
maximal titer found in the B. mori pupal 
hemolymph (Fig. 5C). This activity was 
comparable to or even higher than that 
observed in the N. rileyi conditioned media. 
In contrast, hardly any activity was observed 
in the cellular lysates (Fig. S1A). These 
results confirmed that the cloned cDNA 
encodes E22O and that E22O is a secretory 
protein.   
 Next, we generated an Sf9 cell line 
that stably expressed the E22O cDNA (Sf9-
E22O cell line) and injected its conditioned 
medium into B. mori individuals to test 
whether it would decrease the hemolymph 
ecdysteroid titer and affect their growth. We 
have previously shown that injection of N. 
rileyi conditioned medium into the mid-
penultimate instar larvae of B. mori induced 
precocious pupation (25). Consistent with 
this observation, some of the larvae that were 
injected with Sf9-E22O conditioned medium 
at the beginning of the penultimate instar ate 
food 3-4 days longer than the control, started 
spinning during the instar and pupated 
precociously (Fig. 3A). When the 
conditioned medium was injected into the 
late-penultimate instar larvae, the last larval 
ecdysis was inhibited (Fig. 3B). Injection of 
Sf9-E22O conditioned medium into B. mori 
pupae 2 days after pupation prolonged pupal 
period and interfered with adult emergence 
(Fig. 3, C and D).  In the hemolymph of the 
E22O-injected pupae, the 20E titer decreased 
and instead large amounts of 22-
dehydroecdysone and 22-dehydro-20-
hydroxyecdysone were present on day 4 
when the 20E titer is the highest in the 
control (Figs. 3E and 5C). These results 
indicate that the conditioned media of Sf9-
E22O cells can also be used to reduce the 
20E titer and thereby manipulate the growth 
of B. mori 
 Molt inhibition by E22O in various 
insects- We next examined how E22O would 
affect the developmental programs in insects 
other than B. mori.  E22O-injected last instar 
larvae of a geometrid moth Naxa seriaria 
(Lepidoptera) remained as larvae for much 
longer period than the controls, and 
eventually died without initiating pupation 
(Fig. 4, A and B). Similar results were 
obtained with the last instar larvae of the 
blowfly Lucilia sericata (Diptera) and bean 
bug Riptortus clavatus (Hemiptera). In both 
species, the larval-pupal or nymphal-adult 
metamorphosis was rarely observed after 
E22O injection, while larvae or nymphs 
injected with the control medium completed 
metamorphosis within 2 weeks (Fig. 4, C-F). 
Injection of E22O into the penultimate or last 
instar larvae of the yellow mealworm 
Tenebrio molitor (Coleoptera) completely 
suppressed larval molting and 70% of them 
died as pharate pupae (Table 1). Furthermore, 
70% of E22O-injected prepupae died without 
completing pupation. E22O injection into T. 
molitor pupae interfered with the normal 
adult eclosion and many deformed adults 
with folded or heavily curled wings emerged. 
Thus, E22O blocked molting and 
metamorphosis of additional four species 
belonging to different orders. 
 Transient expression of E22O gene 
in the silkworm- We have recently 
established an in vivo lipofection method to 
express foreign genes in B. mori larvae (28). 
Using this technique, the E22O gene was 
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expressed in B. mori 3rd instar larvae. Four 
days after the lipofection, 0.098 pmol/µl/min 
(=46 ng/ml/min, N=2) of ecdysone-oxidizing 
activity was observed in the plasma of the 
E22O-expessing larvae, indicating that E22O 
gene was successfully expressed in larval 
tissues and expressed E22O protein was 
secreted into hemolymph. The E22O-
expressing larvae continued eating in the 
instar and grew much bigger than the control 
3rd instar larvae (Table 2, Fig. S4A). Some 
of them pupated precociously after ecdysis to 
the 4th instar larvae and feeding food for a 
week, 3-4 days longer than the control 4th 
instar larvae (Fig. S4B). Similar results were 
obtained by expressing E22O in the 4th 
instar larvae (Fig. S4C).  
 Next, the E22O-expressing plasmid 
was lipofected into the spinning last instar 
larvae. Whereas most of these larvae pupated 
normally, 85% of the pupae could not 
complete the pupal-adult metamorphosis (Fig. 
5A). Half of these pupae grew to pharate 
adults but could not eclose from the pupal 
case normally (Fig. S4D).  
 We compared the ecdysteroid titers 
in the hemolymph of the E22O-expressing 
and control pupae. In controls, the total 
ecdysteroid titer increased after pupation, 
reached a peak (~ 5 µg/ml) on day 4, and 
then decreased to the basal level (Fig. 5B); 
the ecdysone and 20E titers on the other hand 
peaked at around 500 ng/ ml on days 2-3 and 
on day 4, respectively, and then decreased 
rapidly (Fig. 5C). These temporal changes of 
total ecdysteroid, ecdysone, and 20E were 
similar to those observed in Manduca sexta 
pupae (36). The sum of the ecdysone and 
20E titers was 800 ng/ ml at the maximum, 
suggesting that the hemolymph contained 
much more amounts of other ecdysteroids 
that could react with the antibody used in 
RIA.   
 In contrast, the total ecdysteroid titer 
continued to increase in the hemolymph of 
the E22O-expressing pupae (Fig. 5B). The 
maximal ecdysone titer (~400 ng/ml) was 
observed on day 2, as in the controls, but 
thereafter the titer maintained a level of more 
than 100 ng/ml (Fig. 5D). The 20E titer did 
not show any obvious peak, but 100-300 
ng/ml of 20E was present throughout the 
pupal period. The maximal 20E titer in the 
E22O-expressing pupae was thus half of that 
in the controls. While 22-dehydroecdysone 
and 22-dehydro-20-hydroxyecdysone were 
not detected in the controls, large amounts of 
22-dehydroecdysteroids, particularly 22-
dehydroecdysone, accumulated in the 
hemolymph of the E22O-expressing pupae 
(Fig. 5D). The affinity of the antibody used 
in RIA to 22-dehydroecdysone was one-tenth 
that to 20E (see EXPERIMENTAL 
PROCEDURES) and therefore the 20E 
equivalent values of the 22-dehydroecdysone 
titers were expected to be very small, 
suggesting that much amounts of 
unidentified ecdysteroids were present also 
in the hemolymph of the E22O-expressing 
pupae. Taken together, these results indicate 
that transient expression of E22O 
dramatically altered the temporal patterns of 
the ecdysteroid titers, and affected both 
larval molting and metamorphosis in B. mori.  
An injection of purified 22-dehydroecdysone 
or 22-dehydro-20-hydroxyecdysone into late 
pupae had no effects (data not shown), 
suggesting that not the accumulation of those 
22-dehydroecdysteroids but the reduction of 
20E at the peak time or its sustained presence 
caused the developmental abnormalities.    
 Transgenic expression of E22O gene 
in the fruit fly- We also examined the effects 
of overexpression of E22O gene in the fruit 
fly Drosophila melanogaster using the 
GAL4/UAS gene expression system (29). 
When the UAS-E22O line was crossed with 
the engrailed-GAL4 line, most (99.8%) of 
the F1 individuals were embryonic lethal. 
They developed to around stage 14 and 
completed segmentation, but then stopped 
further differentiation. The denticle belt was 
not formed in 75% of them (Fig. 6A). Similar 
results were obtained when the UAS-E22O 
line was crossed with the hsp70-GAL4 line 
even without heat shock or crossed with the 
Actin5C-GAL4 line (data not shown). These 
phenotypes were very similar to those of the 
ecdysteroid biosynthesis deficient mutants of 
Drosophila such as disembodied, shadow, 
phantom, spook and shroud (17), suggesting 
that the ecdysteroid contents in the E22O-
expressing embryos were reduced. In fact, at 
the peak time of the embryonic ecdysteroid 
titer in wild type (7-12 h after egg laying, 
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corresponding to stages 12-15) (31), the total 
ecdysteroid titer in the engrailed-
GAL4>UAS-E22O embryos was around half 
that of wild type embryos (Fig. 6B).  
 Induction of diapause in Haritalodes 
basipunctalis by E22O injection- Although it 
is widely accepted that low ecdysteroid titer 
is important for the maintenance of larval 
and pupal diapause (4), it is still unclear 
whether a reduction of ecdysteroid titer is 
sufficient to induce diapause. To resolve this 
issue, we examined the effects of E22O 
injection on larval diapause of the crambid 
moth H. basipunctalis.  
 H. basipunctalis larvae entered 
diapause in the last larval instar after the 
wandering behavior when reared at 17 °C 
under a short day length (diapausing-
inducing condition), whereas they pupated 
and then emerged as adults when reared at 
25 °C under a long day length (non-
diapausing condition) (Fig. 7, A and F). First, 
we verified that the hemolymph ecdysteroid 
titer is kept low in the diapausing H. 
basipunctalis larvae. In the non-diapausing 
last instar larvae, the total ecdysteroid was 
less than 20 ng/ ml during the feeding period 
(Fig. 7L).  It increased drastically after the 
wandering behavior and peaked at around 
600 ng/ml one day before pupation.  In the 
diapausing last instar larvae, the ecdysteroid 
titer was less than 20 ng/ ml during the 
feeding period as in the non-diapausing 
larvae (Fig. 7L). It increased slightly after the 
wandering behavior but did not exceed 40 
ng/ml for subsequent four weeks. Thus, the 
hemolymph ecdysteroid titer was kept at a 
much lower level in the diapausing larvae 
than in the non-diapausing larvae as expected.  
Those differences in the ecdysteroid titers 
between the non-diapausing and diapausing 
H. basipunctalis larvae were very similar to 
those observed in other insects that enter 
diapause facultatively, such as larvae of 
Pimpla instigator (37) and Ostrinia nubilalis 
(38,39) and pupae of M. sexta (40), 
Sarcophaga argyrostoma (41), Boettcherisca 
peregrina (42), and Mamestra brassicae (43).   
 When the conditioned medium of 
Sf9-E22O cells was injected into the non-
diapausing last instar larvae 1 day after the 
wandering behavior, pupation was delayed 
and some individuals remained at the larval 
stage for very long periods (Fig. 7B). When 
those larvae were transferred to diapause-
inducing condition or kept at 5 °C, in both 
cases most of them lived for longer than 2 
months as larvae without eating anything 
(Fig. 7, E and H). These developmental 
characteristics were very similar to those of 
the diapause-destined larvae (Fig. 7, C, F. 
and I) but distinct from those of the intact 
non-diapausing larvae (Fig. 7, A, D, and G). 
Particularly, all of intact non-diapausing 
larvae transferred to 5 °C died within 2 
months, indicating that E22O injection 
rapidly imparted high cold hardiness to H. 
basipunctalis larvae.  
 When the E22O-injected larvae were 
reared under diapause-breaking condition 
(5 °C for 6 weeks and then transferred to 
diapause-inducing condition), they pupated 
and then emerged as adults, as did  
diapausing larvae (Fig. 5, J and K). The 
E22O-injected non-diapausing larvae were 
thus in a physiologically similar state to that 
of the diapausing larvae, which strongly 
suggest that E22O injection induced 
diapause or a diapause-like state in the N. 
basipunctalis larvae. As far as we know, 
these results are the first evidence indicating 
that a reduction in the ecdysteroid titer is a 
sufficient endocrinological stimulus to 
induce diapause in insects.  
 
 
DISCUSSION 
 We have characterized the 
ecdysteroid inactivation enzyme E22O from 
an entomopathogenic fungus N. rileyi and 
have shown that both injection of the 
recombinant E22O protein and forced 
expression of the E22O gene reduce the 
internal ecdysteroid titer and affect the 
development and physiology of several 
insect taxa. The E22O-modified phenomena 
included embryogenesis, larval-larval molt, 
larval-pupal metamorphosis, pupal- or 
nymphal-adult metamorphosis, and diapause. 
Thus, E22O influenced most of the major 
ecdysteroid-regulated events during insect 
development. 
 Injection of recombinant E22O 
protein or transient expression of the E22O 
gene inhibited molting and metamorphosis in 
various insect species. In N. seriaria, L. 
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sericata and R. clavatus, the E22O-injected 
last instar larvae or nymphs remained at the 
stage they were injected for a long period 
until they died without initiating molt. It is 
most likely that the injected E22O 
maintained the titers of ecdysteroids in the 
hemolymph, particularly that of 20E, below 
the thresholds to induce metamorphosis in 
these species. In contrast, more than half of 
E22O-injected B. mori and T. molitor larvae 
eventually initiated molting responses, 
suggesting that E22O was unable to 
completely suppress the rise of ecdysteroid 
titer. In fact, lower but significant level of 
20E was found in B. mori pupae that were 
injected with E22O or forced to express the 
E22O gene. These results imply that the 
effectiveness of E22O for inactivating 
ecdysteroids varies according to the insect 
species.   
 Reduction of ecdysteroid titers either 
by injection of E22O protein or by 
expression of E22O gene induced precocious 
metamorphosis in B. mori.  These results 
may appear strange because precocious 
metamorphosis is widely known to be a 
typical phenotype of the lack of juvenile 
hormone (1).   However, it was also reported 
that the B. mori 4th instar larvae, in which 
the ecdysteroid synthesis was suppressed by 
using the imidazole compound KK-42, 
pupated precociously (44). In addition, there 
are some reports showing that the 
ecdysteroid deficiency causes precocious 
metamorphosis also in D. melanogaster (45-
47). The precocious pupation in D. 
melanogaster, induced as a result of lowered 
ecdysteroid titer, was explained as follows: 
due to the low ecdysteroid titer, the 
penultimate instar larvae were unable to 
initiate the last larval-larval molt and kept on 
feeding, and consequently grew to the point 
where they surpassed the 'critical weight for 
precocious pupation', although what 
eventually initiated the precocious pupation 
still remains unknown (46).  Since the 4th 
larval period of the E22O-treated B mori 
larvae was also prolonged, a similar 
mechanism may underlie in the induction of 
precocious pupation in B. mori.   
 Among the multiple applications of 
E22O tested here, transgenic insects carrying 
the E22O gene seem to be an ideal system 
for controlling the ecdysteroid titer at any 
stage of the development. The E22O-
expressing transgenic D. melanogaster were, 
however, all embryonic lethal irrespective of 
the GAL4 driver lines used. These results 
were in contrast to those of the ecdysteroid 
26-hydroxylase (cyp18A1)-expressing flies, 
where the time of death changed from the 
embryonic stage to the last larval instar stage 
depending on the GAL4 driver line used for 
crossing (21). Thus, contrary to our 
expectation, the E22O gene appears too 
strong to use in transgenic flies, suggesting 
that mutations to moderate the enzymatic 
activity of E22O may be necessary for its 
transgenic use.   
 Using E22O, we not only confirmed 
the importance of ecdysteroids in 
embryogenesis, larval molting and 
metamorphoses, but also answered an 
unsolved question associated with diapause. 
E22O-injected H. basipunctalis last instar 
larvae remained as larvae for a long period as 
found with N. seriaria, L. sericata and R. 
clavatus. We assumed that this was not a 
simple developmental arrest, but an 
artificially induced diapause or a diapause-
like state based on the following three 
reasons. First, the E22O-injected H. 
basipunctalis larvae survived much longer 
than the above three species without eating 
anything. Second, they acquired high cold-
hardiness, a characteristic often observed in 
insects in diapause (4). Finally, and more 
importantly, they resumed development after 
being exposed to chilling condition, which is 
the environmental stimulus to break diapause 
in many insect species (4). These 
developmental and survival characteristics 
were indistinguishable from those of the 
normal diapause-destined larvae. Many 
researches suggested that larval and pupal 
diapauses are maintained by the ecdysteroid 
deficiency (37-43). The hemolymph 
ecdysteroid titer was kept at a low level also 
in diapausing H. basipunctalis larvae. 
However, the endocrinological cue to trigger 
diapause is still not very clear while a low 
ecdysteroid titer is obviously necessary for 
insects to enter diapause. Our results strongly 
suggest that a reduction in the ecdysteroid 
titer is a key signal to coordinately induce 
multiple diapause-associated physiological 
 10 
changes in N. basipunctalis including 
developmental arrest, enhancement of cold 
hardiness and programming to resume 
development, although more detailed 
measurement of ecdysteroid titer and 
examination of other physiological properties 
would be necessary to achieve the final goal. 
It would also be interesting to use E22O to 
examine whether ecdysteroids play a similar 
role in inducing larval or pupal diapause in 
other insects.  
 In conclusion, the potent ecdysteroid 
inactivation enzyme E22O could be used as 
an artificial ecdysteroid titer-reducing tool to 
manipulate multiple ecdysteroid-regulated 
phenomena.  Particularly, injection of 
recombinant E22O protein, a relatively 
simple technique, is potentially applicable to 
all insects and other arthropods.  Judicious 
applications of methods utilizing E22O could 
obtain answers to a wide range of 
ecdysteroid-associated developmental and 
physiological questions, including 
uncovering new functions of ecdysteroids. 
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Figure legends: 
FIGURE 1. Enzymatic reactions of E22O. E22O oxidizes the hydroxyl group at position C22 of 
ecdysone and 20-hydroxyecdysone to a carbonyl group.  The oxidized ecdysteroids lose hormonal 
activity.   
 
FIGURE 2. Purification and biochemical characterization of E22O. A-C, E22O was purified from 
the N. rileyi conditioned medium by sequential use of Phenyl-Sepharose HP hydrophobic interaction 
chromatography (A), Superdex 200 pg gel-filtration chromatography (B), and HiTrap Q column 
chromatography (C). Fractions indicated using the hatched bars in (A) and (B) were pooled and 
purified further in (B) and (C), respectively. Fractions indicated using the closed bar in (C) contained 
pure E22O; they were pooled and then used for further biochemical analyses. D, E,  Molecular mass 
of E22O was determined by SDS-PAGE (D) and Superdex-200 pg gel-filtration chromatography (E). 
F, Kinetic analysis. Various concentrations of ecdysone or 20-hydroxyecdysone were incubated with 
2.5 ng/ 50 µl of purified E22O in phosphate buffer (pH 7.0) and amounts of 22-dehydroecdysteroids 
formed were measured after 10 min. Kcat values were calculated using the molecular mass of E22O as 
76 kDa.  
 
FIGURE 3. Effects of E22O injection on growth and hemolymph ecdysteroid titer of B. mori. A, 
Precocious pupation induced by injection of 30 µl of Sf9-E22O conditioned medium into newly 
molted penultimate (4th) instar larvae. Left: a control pupa metamorphosed from an intact 5th instar 
larva; right: a miniature precocious pupa induced by E22O injection. Ten % of the E22O-injected 
larvae started spinning a week later and half of them pupated precociously. B, Molting of the 
penultimate instar larvae after injecting 30 µl of the conditioned medium of either Sf9 (control) or Sf9-
E22O cells just before the head capsule slippage (day 3.5). C, Pupal development after injecting 30 µl 
of the conditioned medium of either Sf9 (control) or Sf9-E22O 2 days after pupation. D, Pupal period 
of control and E22O injected-pupae.  Only pupae that eclosed as adults normally were included in the 
calculation. Asterisks (**) indicate that the values are significantly different  (p<0.01) by Student's t-
test. E, Ecdysteroid titers of control and E22O injected-pupae on day 4 (2 days after the medium 
injection). Error bars represent SEM (N=4). 
 
FIGURE 4. Effects of E22O injection on the growth of three insects. Last instar larvae or nymphs 
were injected with 30 µl (for N. seriaria) or 5 µl (for L. sericata and R. clavatus) of conditioned 
culture medium of either the control Sf9 cell cells (A, C, E) or Sf9-E22O cells (B, D, F), and 
subsequently their growth was observed. Eighty to 160 individuals were used for each experiment.  
 
FIGURE 5. Effects of transient E22O expression in spinning silkworm on the growth and 
ecdysteroid titer. A, Effects of E22O expression on the pupal development.  Plasmid pIZT-E22O and 
control plasmid pIZT/V5-his were introduced separately by in vivo lipofection into the spinning last 
instar larvae and developments of normally pupated individuals were observed. B, Changes in the total 
ecdysteroid titer (20E equivalent) in the hemolymph of non-lipofected control and E22O-expressing 
pupae. C, D, Changes in the titer of each ecdysteroid in the hemolymph of the non-lipofected control 
(C) and E22O-expressing pupae (D). Error bars represent SEM (N=3-8).  
 
FIGURE 6. Effects of transgenic E22O expression in D. melanogaster embryo. A, A typical 
phenotype of engrailed-GAL4>UAS-E22O embryo. Left: wild type, right: engrailed-GAL4>UAS-
E22O. Note that even though the segmentation was completed, the denticle belt was not formed in the 
transgenic fly. B, Comparison of the total ecdysteroid titer (20E equivalent) between the wild type and 
engrailed-GAL4>UAS-E22O embryos. The ecdysteroid titer was measured in batches of eggs 
collected 7-12 hours after the oviposition. Error bars represent SEM (N=6-8). Asterisks (**) indicate 
that the values are significantly different  (p<0.01) by Student's t-test. 
 
FIGURE 7. Growth, survival, and ecdysteroid titer of H. basipunctalis larvae under different 
conditions. Non-diapausing larvae reared under non-diapausing conditions (A, D, G), non-diapausing 
larvae injected with 30 µl of the conditioned culture medium of the Sf9-E22O cells 1 day after 
 14 
wandering (B, E, H), and diapause-destined larvae reared under diapause-inducing conditions (C, F, I) 
were reared under non-diapausing condition (A-C), diapause-inducing condition (D-F), or at 5°C (G-I) 
after wandering, and their subsequent growth and survival were monitored. The E22O-injected non-
diapausing larvae (J) and intact diapause-destined larvae (K) were reared also under diapause-breaking 
condition and their growth was monitored. Sixty to 300 larvae were used for each experiment. L, 
Changes in the total ecdysteroid titer (20E equivalent) in the hemolymph of non-diapausing and 
diapausing last instar larvae. Larvae were reared under the non-diapausing and diapause-inducing 
conditions continuously.  Their growth are shown in A and F, respectively. Error bars represent SEM 
(N=2-17). 
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